Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells.
Not exact matches
One potential treatment approach could involve linking a cytotoxin to a specific protein binder (as a
small -
molecule drug conjugate or SMDC).
Not a light read, this tome is bursting with information about monoclonal antibodies, from the history of how these therapies were first developed to new approaches such as
conjugate therapy, which combines antibodies with
small -
molecule drugs.
Accomplishments: * Actively consulting on, discovery and development of Antibody
Drug Conjugates (ADCs) * Actively consulting on,
small molecules process optimization, scale - up and regulatory aspects * Sepsis diagnostic kits (mAb based) business to Asia for development, manuf.
Senior manager and director of pharmaceutical process chemistry, manufacturing and controls (CMC) specializing in cGMP, quality and regulatory compliance of novel
small and large
molecule therapeutic
drugs including peptides, nucleotides, protein biologics and antibody
drug conjugates (ADCs).